- Home
- VOR vs AVNS Comparison
VOR vs AVNS Comparison
Compare VOR & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | AVNS |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 702.4M | 659.5M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VOR | AVNS |
|---|---|---|
| Price | $13.93 | $24.65 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $45.33 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $701,200,000.00 |
| Revenue This Year | N/A | $3.28 |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $0.13 | $9.30 |
| 52 Week High | $49.95 | $24.75 |
Technical Indicators
Market Signals| Indicator | VOR | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 90.37 |
| Support Level | $11.74 | $10.90 |
| Resistance Level | $16.87 | $24.73 |
| Average True Range (ATR) | 1.00 | 0.07 |
| MACD | -0.22 | -0.01 |
| Stochastic Oscillator | 5.66 | 62.50 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.